Meticulous Research®, a leading authority in market intelligence, has released a comprehensive report titled, “Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), End User (Pharma, Academic) - Global Forecast to 2029.” The report anticipates that the global cell culture market will expand at a robust CAGR of 11.7% from 2022 to 2029, reaching an estimated value of $48.63 billion by the end of the forecast period.
Download Free Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=4788?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=17-09-2024
The cell culture market's significant growth is driven by the expanding biopharmaceutical sector, the increasing prevalence of chronic diseases, and the rising demand for monoclonal antibodies. Additional factors such as enhanced research funding and the adoption of single-use technologies further accelerate market expansion. Furthermore, emerging trends like 3D cell culture and personalized medicine present substantial growth opportunities for industry stakeholders.
COVID-19 Pandemic: A Catalyst for Cell Culture-Based Research
The COVID-19 pandemic underscored the critical role of cell culture in advancing research aimed at understanding virus transmission and developing effective therapeutic strategies. Early in the pandemic, the Centers for Disease Control and Prevention (CDC) distributed the SARS-CoV-2 virus strain to global research communities, enabling extensive study of the virus. In vitro cell culture models, including human lung epithelium and various other human airway models, became pivotal in antiviral research, vaccine development, and virus pathogenesis studies, significantly impacting the demand for cell culture products.
Market Segmentation Insights
The report provides an in-depth analysis of the cell culture market segmented by product, application, end user, and geography:
• Product Segment: The market is bifurcated into consumables and equipment. In 2022, consumables are projected to command the largest market share, driven by the consistent need for media, reagents, sera, and cell lines across all stages of the cell culture process.
• Application Segment: The market is categorized into bioproduction, cancer research, drug screening & development, stem cell research, and other applications. Bioproduction is expected to dominate this segment in 2022, fueled by the escalating demand for biopharmaceutical products, including monoclonal antibodies, vaccines, therapeutic proteins, and gene therapies.
• End User Segment: Pharmaceutical & biotechnology companies are anticipated to hold the largest share of the market in 2022, attributed to the growing number of biotech start-ups, expanded production and research activities, and the presence of key industry players.
• Geographical Analysis: North America is forecasted to lead the global cell culture market in 2022, followed by Europe and the Asia-Pacific region. The dominance of North America is attributed to its well-established healthcare infrastructure, rapid adoption of advanced technologies, and significant investments in pharmaceutical research.
Key Market Players
The report identifies key players in the global cell culture market, including Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Cytiva (U.S.), Lonza Group Ltd. (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and Company (U.S.), Avantor, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), HiMedia Laboratories (India), Sartorius AG (Germany), Eppendorf SE (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Getinge AB (Sweden), Greiner Bio-One GmbH (Austria), and Miltenyi Biotec B.V. & Co. KG (Germany).
Quick Buy @ https://www.meticulousresearch.com/Checkout/94004198?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=17-09-2024
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research